SWMP
BIIB icon

Signature Wealth Management Partners’s Biogen BIIB Stock Holding History

Signature Wealth Management Partners’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-1,408
Closed -$338K – 114
2021
Q4 		$338K Sell
1,408
-950
-40% -$244K 0.29% 75
2021
Q3 		$667K Hold
2,358
– – 0.6% 42
2021
Q2 		$817K Buy
2,358
+260
+12% +$78.8K 0.74% 33
2021
Q1 		$587K Buy
2,098
+1,000
+91% +$270K 0.56% 49
2020
Q4 		$269K Buy
+1,098
New +$283K 0.27% 75

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

Signature Wealth Management Partners's BIIB Position: Q1 2022 in Review

Signature Wealth Management Partners sold out of Biogen (BIIB) in Q1 2022, closing a stake of 1,408 shares — an estimated $338K sold.

Signature Wealth Management Partners first reported a position in BIIB in Q4 2020 and held it in 5 quarters. The position peaked at $817K in Q2 2021. 953 funds tracked by Wall St. Rank hold BIIB as of Q1 2022.

  • Signature Wealth Management Partners reported no remaining Biogen position as of Q1 2022 after selling out during the quarter.
  • Signature Wealth Management Partners sold 1,408 Biogen shares in Q1 2022, an estimated $338K.
  • Signature Wealth Management Partners first reported a position in Biogen in Q4 2020 and held it in 5 quarters.
  • Signature Wealth Management Partners's Biogen position peaked at $817K in Q2 2021.
  • 953 funds tracked by Wall St. Rank held Biogen as of Q1 2022.

Based on Signature Wealth Management Partners's 13F filing for Q1 2022, filed 10 May 2022.